FDA issued a Warning Letter to Tris Pharma Inc. on 3/26/2018 as a result of this inspection.
FDA investigators audited the Tris Pharma - Monmouth Junction, NJ, United States facility and issued inspectional observations (via FDA 483) on 20 Mar 2017.
Add To Cart
- Category: Human Drugs
- Inspection end: 20 Mar 2017
- Location: Monmouth Junction, United States
- FEI: 3004712471